Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JX-594 (Pexa-Vec) in Advanced Hepatocellular Carcinoma
NCT01387555Phase 2Completed
- Sponsor
- Jennerex Therapeutics
- Start
- Oct 2011
- Primary completion
- Oct 2013
- Modality
- Oncolytic Viruses
- Countries
- 7
01
Overview
A Phase 2 trial of vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus in hepatocellular carcinoma (HCC), sponsored by Jennerex Therapeutics. Started Oct 2011; status: completed.
02
Drugs
vaccinia granulocyte-macrophage colony-stimulating factor recombinant virus
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01387555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387555.